KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Solid Tumors With HRAS Alterations · Non Small Cell Lung Cancer (NSCLC) · Colorectal Cancer (CRC) · Pancreatic Ductal Adenocarcinoma (PDAC) · Clear Cell Renal Cell Carcinoma (ccRCC) · Renal Cell Carcinoma (Kidney Cancer) · Non Clear Cell Renal Cell Carcinoma (nccRCC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona, United States
University of Arizona, Tucson, Arizona, United States
University of Southern California, Los Angeles, California, United States
Contact: Study coordinator (Xiomara Menendez, RN) · Xiomara.Menendez@med.usc.edu · 323-865-3000
Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Study coordinator (William Mills) · william.mills@cshs.org · 310-423-0102
UCLA Department of Medicine, Los Angeles, California, United States
Contact: Study coordinator (Christopher Lim) · christopherlim@mednet.ucla.edu · 310-633-8400
Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
Study coordinator · CANN.DDUDenverGeneral@sarahcannon.com · 720-754-2610
AdventHealth Celebration, Celebration, Florida, United States
Contact: Study coordinator (Amy Whitaker) · amy.whitaker@adventhealth.com
Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida, United States
Florida Cancer Specialists, Sarasota, Florida, United States
Contact: Study coordinator (Nancy Olsen) · nolsen@flcancer.com
University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States
Contact: Study coordinator (Mimi McKay) · 319-353-8155
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Kailene Sullivan, RN) · kailene_sullivan@dfci.harvard.edu
Henry Ford Health System, Detroit, Michigan, United States
Contact: Study coordinator (Bethany Adams, RN) · badams19@HFHS.ORG · 248-224-7345
Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, United States
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Study coordinator (Jessica Ley) · jcley@wustl.edu · 314-747-8092
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Contact: Study coordinator (Mohammad Ghalib) · mhg68@cinj.rutgers.edu · 718-405-8515
Ohio State University, Columbus, Ohio, United States
OU Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Contact: Study coordinator (Christina Caldwell) · Christina-Caldwell@ouhsc.edu · 405-271-8001
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Immunotherapy and Drug Development Center (IDDC) Referrals) · ClinicalResearchServicesHCCIDDC@upmc.edu
SCRI - Oncology Partners, Nashville, Tennessee, United States
Study coordinator · 844-482-4812
UT Southwestern Simmons Cancer Center, Dallas, Texas, United States
Contact: Study coordinator (Tian Zhang, MD) · Tian.Zhang@utsouthwestern.edu
MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Ly M Nguyen) · lmnguyen1@mdanderson.org · (832) 794-3672
University of Wisconsin (Carbone Cancer Center), Madison, Wisconsin, United States
Contact: Study coordinator (UW Carbone Cancer Center - Cancer Connect) · clinicaltrials@cancer.wisc.edu · 800-622-8922
Centre Leon Berard, Lyon, France
Oncologie médicale - Pitié-Salpêtrière, Paris, France
Contact: Study coordinator (Marianne Veyri) · marianne.veyri@aphp.fr
Hopital Européen Georges Pompidou, Paris, France
Contact: Study coordinator (Anna Farran) · anna.farran@aphp.fr
Contact: Study coordinator (Clémentine Drain) · clementine.drain@aphp.fr
Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
Charité - Universitätsmedizin Berlin, Berlin, Germany
Universitätsklinikum Ulm, Ulm, Germany
Universitätsklinikum Würzburg, Würzburg, Germany
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS, Bologna, Italy
Contact: Study coordinator (Serena Aloi) · serena.aloi@aosp.bo.it
Contact: Study coordinator (Mirela Giordano) · mirela.giordano@aosp.bo.it
Fondazione Piemonte per l'Oncologia - IRCCs Candiolo, Candiolo, Italy
Contact: Study coordinator (Vanesa Gregorc, MD) · Vanesa.gregorc@ircc.it
Istituto Nazionale Tumori IRCCS, Naples, Italy
Humanitas University, Rozzano, Italy
AOU Verona - Centro Ricerche Cliniche di Verona, Verona, Italy
Contact: Study coordinator (Andrea Zivi, MD) · andrea.zivi@aovr.veneto.it
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Contact: Study coordinator (Paula Barranco) · paulabarranco@vhio.net
Hospital de la Santa Creu i de Sant Pau, Barcelona, Spain
Contact: Study coordinator (Mireia Llobet Busquets) · mllobetb@santpau.cat
Contact: Study coordinator (Phase 1 Center) · IR_fases1onco@santpau.cat
Hospital HM Sanchinarro START Madrid-CIOCC, Madrid, Spain
Contact: Study coordinator (Maria Garrido, RN) · maria.garrido@startmadrid.com
Contact: Study coordinator (Esther Ordoñez) · esther.ordonez@startmadrid.com
Hospital Universitario Virgen del Rocío, Seville, Spain
Contact: Study coordinator (Rosa María Ballesteros) · rballesteros.oncologiahuvr@gmail.com

View source on ClinicalTrials.gov